LIFECORE BIOMEDICAL, INC. \DE\ Common Stock Shares Outstanding

Quick Answer

LIFECORE BIOMEDICAL, INC. \DE\ reported Common Stock Shares Outstanding of 37.03 million shares for the year ending 2025.

  • LIFECORE BIOMEDICAL, INC. \DE\ showed an increase of +21.1% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from LIFECORE BIOMEDICAL, INC. \DE\'s annual report (Form 10-K), filed with the SEC on August 7, 2025.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 15 years of available data (2011 to 2025), LIFECORE BIOMEDICAL, INC. \DE\'s Common Stock Shares Outstanding has grown by 40.2%.
  • Historical annual values: Fiscal year 2025: 37.03 million shares | Fiscal year 2024: 30.56 million shares | Fiscal year 2023: 30.32 million shares | Fiscal year 2022: 29.51 million shares | Fiscal year 2021: 29.33 million shares | Fiscal year 2020: 29.22 million shares | Fiscal year 2019: 29.10 million shares | Fiscal year 2018: 27.70 million shares | Fiscal year 2017: 27.50 million shares | Fiscal year 2016: 27.15 million shares | Fiscal year 2015: 26.99 million shares | Fiscal year 2014: 26.82 million shares | Fiscal year 2013: 26.40 million shares | Fiscal year 2012: 25.64 million shares | Fiscal year 2011: 26.41 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: